Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
63 |
|
| Actual shortage: | 25 (40%) | |
| Anticipated shortage: | 1 (2%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 37 (59%) | |
Discontinuation Reports |
11 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 11 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
8 (11%) |
|
Overdue reports |
1 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-IRBESARTAN/HCTZ | 12.5MG 300.0MG | TABLET | Resolved | 2019-01-03 | 2019-01-16 | 71060 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300.0MG | TABLET | Actual shortage | 2019-01-16 | 2019-04-08 | 72666 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 150.0MG | TABLET | Actual shortage | 2019-04-08 | 2019-04-09 | 80792 |
| MINT-IRBESARTAN/HCTZ | 25.0MG 300.0MG | TABLET | Actual shortage | 2019-04-08 | 2019-04-09 | 80797 |
| MINT-LEVOCARB | 10MG 100MG | TABLET | Actual shortage | 2017-12-08 | 2017-12-09 | 32263 |
| MINT-LEVOCARB | 25MG 100MG | TABLET | Actual shortage | 2017-12-08 | 2017-12-09 | 32270 |
| MINT-LEVOCARB | 25MG 250MG | TABLET | Actual shortage | 2017-12-08 | 2017-12-09 | 32274 |
| MINT-LOSARTAN | 100.0MG | TABLET | Actual shortage | 2019-01-03 | 2019-04-08 | 71066 |
| MINT-LOSARTAN | 25.0MG | TABLET | Actual shortage | 2019-01-03 | 2019-04-08 | 71069 |
| MINT-LOSARTAN | 50.0MG | TABLET | Actual shortage | 2019-01-03 | 2019-04-08 | 71074 |
| MINT-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Actual shortage | 2019-02-04 | 2019-04-08 | 74450 |
| MINT-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Actual shortage | 2019-04-08 | 2019-04-09 | 80808 |
| MINT-LOSARTAN/HCTZ DS | 25.0MG 100.0MG | TABLET | Actual shortage | 2019-04-08 | 2019-04-09 | 80811 |
| MINT-METFORMIN | 500MG | TABLET | Actual shortage | 2019-02-04 | 2019-02-05 | 74455 |
| MINT-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2018-04-12 | 2018-05-04 | 45542 |
| MINT-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-09 | 2018-07-25 | 35467 |
| MINT-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-09 | 2018-07-25 | 35470 |
| MINT-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-09 | 2018-07-25 | 35473 |
| MINT-ONDANSETRON | 4MG | TABLET | Resolved | 2017-10-26 | 2018-03-10 | 27164 |
| MINT-ONDANSETRON | 8MG | TABLET | Resolved | 2017-10-26 | 2017-11-22 | 27173 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58283 |
| MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58286 |
| MINT-CLOPIDOGREL | Discontinued | 2019-02-04 | 2019-02-05 | 74435 | ||
| MINT-CLOPIDOGREL | Discontinued | 2019-02-04 | 2019-02-05 | 74442 | ||
| MINT-RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13556 |
| MINT-RIVASTIGMINE | 6MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13559 |
| MINT-RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13562 |
| MINT-RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13565 |
| MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
| MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
| MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |